Health Equity and Decentralized Trials
Jennifer Dahne, Larry W. Hawk
Abstract
This Viewpoint discusses the proliferation of decentralized clinical trials during the COVID-19 pandemic and the need for rigorous studies to inform whether decentralized approaches promote or prevent access to clinical trials for people facing health disparities.
Topics & Concepts
MedicinePandemicClinical trialEquity (law)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakHealth equityPublic healthVirologyNursingInfectious disease (medical specialty)DiseasePathologyOutbreakLawPolitical scienceEthics in Clinical ResearchHealth Systems, Economic Evaluations, Quality of LifeHealthcare cost, quality, practices